AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 97 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,020,000 | -64.1% | 116,700 | -82.6% | 0.06% | -69.4% |
| Q2 2020 | $11,195,000 | +13.2% | 670,000 | -2.3% | 0.20% | -21.0% |
| Q1 2020 | $9,888,000 | +7.4% | 685,716 | +149.4% | 0.25% | +21.0% |
| Q4 2019 | $9,204,000 | -0.1% | 275,000 | -37.5% | 0.20% | -19.3% |
| Q3 2019 | $9,214,000 | -1.7% | 440,000 | -2.2% | 0.25% | +18.1% |
| Q2 2019 | $9,369,000 | +42.1% | 450,000 | +52.5% | 0.22% | +152.9% |
| Q1 2019 | $6,595,000 | +12.5% | 295,100 | +20.4% | 0.08% | +9.0% |
| Q4 2018 | $5,860,000 | +43.2% | 245,000 | +63.3% | 0.08% | +52.9% |
| Q3 2018 | $4,092,000 | +1.4% | 150,000 | 0.0% | 0.05% | -10.5% |
| Q2 2018 | $4,034,000 | -20.8% | 150,000 | -6.2% | 0.06% | -46.2% |
| Q1 2018 | $5,093,000 | +573.7% | 160,000 | +700.0% | 0.11% | +562.5% |
| Q4 2017 | $756,000 | -56.4% | 20,000 | -71.4% | 0.02% | -62.8% |
| Q3 2017 | $1,735,000 | -47.3% | 70,000 | -56.2% | 0.04% | -34.8% |
| Q2 2017 | $3,290,000 | – | 160,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|